Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
BioVascular Inc logo — Pioneering innovative solutions for platelet-mediated cardio...

BioVascular Inc

Pioneering innovative solutions for platelet-mediated cardiovascular diseases with a groundbreaking polypeptide treatment.

Founded 2006 2-10 employees Series C Total: $10.87M Biotechnology, Health Care

General Information

Company Name BioVascular Inc
Founded Year 2006
Employees 2-10
Industries Biotechnology, Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with BioVascular Inc. To contact BioVascular Inc, visit biovascularinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioVascular Inc compare?

A PDF of BioVascular Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioVascular Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioVascular Inc

BioVascular Inc. is a pioneering biotechnology company focused on developing innovative products for platelet-mediated cardiovascular diseases. Their groundbreaking polypeptide treatment, saratin, is produced through recombinant technology in yeast and is currently undergoing human clinical trials for use in hemodialysis access grafts and peripheral artery grafts. The treatment aims to reduce intimal hyperplasia, a condition that can lead to graft failure. Founded in 2006, the company received a $10.87M Series C investment on 07 February 2008 from Domain Associates, BB Biotech Ventures, and Merck. Specializing in the biotechnology and healthcare industries, BioVascular is at the forefront of developing solutions to address critical cardiovascular challenges.

Business keywords: cardiovascular diseases, clinical-stage, polypeptide treatment, recombinant technology, clinical trials, hemodialysis access grafts, peripheral artery grafts, intimal hyperplasia, Merck KGaA, innovative products, platelet-mediated, startup, investor, data analyst

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $10.87M 3
Domain Associates BB Biotech Ventures Merck
Domain Associates, BB Biotech Ventures +1
07 Feb 2008

BioVascular Inc Alternatives & Competitors

BioVascular Inc vs
Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals United States

Rescue cells. Change lives.

Venture round
12 employees
Biotechnology, Health Care
BioVascular Inc vs
CryoTherapeutics SA
CryoTherapeutics SA Belgium

Using cryotherapy to stabilize vulnerable plaque and reduce the risk of heart attack

Series B
25 employees
Biotechnology, Health Care

FAQ About BioVascular Inc

Pioneering innovative solutions for platelet-mediated cardiovascular diseases with a groundbreaking polypeptide treatment.
BioVascular Inc was founded in 2006.
BioVascular Inc operates in Biotechnology and Health Care. Its work centres on cardiovascular diseases, clinical-stage, polypeptide treatment and recombinant technology.
BioVascular Inc has approximately 2-10 employees.
BioVascular Inc has completed 1 funding round, raising a total of $10.87M. The latest funding stage is Series C.
Top alternatives and competitors to BioVascular Inc include Silver Creek Pharmaceuticals, CryoTherapeutics SA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioVascular Inc and Silver Creek Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioVascular Inc, https://bouncewatch.com/company/biovascular, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout